 | • レポートコード：QY2108PAL4051 • 出版社/出版日：QYResearch / 2021年8月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品 |
| Single User | ￥735,000 (USD4,900) | ▷ お問い合わせ |
| Multi User | ￥1,102,500 (USD7,350) | ▷ お問い合わせ |
| Enterprise License | ￥1,470,000 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査資料はバルプロミドの世界市場の現状について調査・分析し、2027年までの市場を予測しました。バルプロミドの世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（ピル、カプセル、坐剤）、用途別市場規模（病院、薬局、その他）、主要地域別市場規模（北米・アメリカ、ヨーロッパ、アジア・日本・中国・インド、中南米、中東・アフリカ）、関連企業の情報、バリューチェーン・販売チャネル、市場動向などを収録しています。 ・バルプロミドの世界市場概要 ・メーカー別の競争状況、市場シェア ・バルプロミドの種類別市場規模：ピル、カプセル、坐剤 ・バルプロミドの用途別市場規模：病院、薬局、その他 ・北米のバルプロミド市場規模2016-2027：種類別、用途別、国別（アメリカ、カナダ） ・ヨーロッパのバルプロミド市場規模2016-2027：種類別、用途別、国別（ドイツ、フランス、イギリス） ・アジアのバルプロミド市場規模2016-2027：種類別、用途別、国別（日本、中国、インド、韓国） ・中南米のバルプロミド市場規模2016-2027：種類別、用途別、国別（メキシコ、ブラジル） ・中東・アフリカのバルプロミド市場規模2016-2027：種類別、用途別、国別（トルコ、サウジアラビア） ・企業情報：China Resources Double-Crane Pharmaceutical Co., Ltd.、Beijing Sail Biopharmaceutical Co., Ltd.、Hunan Xiangzhong Pharmaceutical Co., Ltd.、Shanxi Luliang Traditional Chinese Medicine Factory、Hunan Hansen Pharmaceutical Co., Ltd.、Hunan Dino Pharmaceutical Co., Ltd.、Novartis Pharmaceuticals ・バルプロミドのバリューチェーン・販売チャネル分析 ・バルプロミドの世界市場動向 |
Valpromide is used to prevent and treat various types of epilepsy, with fast onset, strong effect and low toxicity.
Market Analysis and Insights: Global Valpromide Market
The global Valpromide market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027.
Global Valpromide Scope and Segment
Valpromide market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Valpromide market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.
Segment by Type
Pill
Capsule
Suppository
Segment by Application
Hospital
Pharmacy
Others
By Company
China Resources Double-Crane Pharmaceutical Co., Ltd.
Beijing Sail Biopharmaceutical Co., Ltd.
Hunan Xiangzhong Pharmaceutical Co., Ltd.
Shanxi Luliang Traditional Chinese Medicine Factory
Hunan Hansen Pharmaceutical Co., Ltd.
Hunan Dino Pharmaceutical Co., Ltd.
Novartis Pharmaceuticals
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
1 Study Coverage
1.1 Valpromide Product Introduction
1.2 Market by Type
1.2.1 Global Valpromide Market Size Growth Rate by Type
1.2.2 Pill
1.2.3 Capsule
1.2.4 Suppository
1.3 Market by Application
1.3.1 Global Valpromide Market Size Growth Rate by Application
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Valpromide Sales Estimates and Forecasts 2016-2027
2.2 Global Valpromide Revenue Estimates and Forecasts 2016-2027
2.3 Global Valpromide Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Valpromide Regions by Sales
2.4.1 Global Top Valpromide Regions by Sales (2016-2021)
2.4.2 Global Top Valpromide Regions by Sales (2022-2027)
2.5 Global Top Valpromide Regions by Revenue
2.5.1 Global Top Valpromide Regions by Revenue (2016-2021)
2.5.2 Global Top Valpromide Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Valpromide Sales by Manufacturers
3.1.1 Global Top Valpromide Manufacturers by Sales (2016-2021)
3.1.2 Global Top Valpromide Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Valpromide Sales in 2020
3.2 Global Valpromide Revenue by Manufacturers
3.2.1 Global Top Valpromide Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Valpromide Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Valpromide Revenue in 2020
3.3 Global Valpromide Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Valpromide Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Valpromide Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Valpromide Sales by Type
4.1.1 Global Valpromide Historical Sales by Type (2016-2021)
4.1.2 Global Valpromide Forecasted Sales by Type (2022-2027)
4.1.3 Global Valpromide Sales Market Share by Type (2016-2027)
4.2 Global Valpromide Revenue by Type
4.2.1 Global Valpromide Historical Revenue by Type (2016-2021)
4.2.2 Global Valpromide Forecasted Revenue by Type (2022-2027)
4.2.3 Global Valpromide Revenue Market Share by Type (2016-2027)
4.3 Global Valpromide Price by Type
4.3.1 Global Valpromide Price by Type (2016-2021)
4.3.2 Global Valpromide Price Forecast by Type (2022-2027)
5 Market Size by Application
5.1 Global Valpromide Sales by Application
5.1.1 Global Valpromide Historical Sales by Application (2016-2021)
5.1.2 Global Valpromide Forecasted Sales by Application (2022-2027)
5.1.3 Global Valpromide Sales Market Share by Application (2016-2027)
5.2 Global Valpromide Revenue by Application
5.2.1 Global Valpromide Historical Revenue by Application (2016-2021)
5.2.2 Global Valpromide Forecasted Revenue by Application (2022-2027)
5.2.3 Global Valpromide Revenue Market Share by Application (2016-2027)
5.3 Global Valpromide Price by Application
5.3.1 Global Valpromide Price by Application (2016-2021)
5.3.2 Global Valpromide Price Forecast by Application (2022-2027)
6 North America
6.1 North America Valpromide Market Size by Type
6.1.1 North America Valpromide Sales by Type (2016-2027)
6.1.2 North America Valpromide Revenue by Type (2016-2027)
6.2 North America Valpromide Market Size by Application
6.2.1 North America Valpromide Sales by Application (2016-2027)
6.2.2 North America Valpromide Revenue by Application (2016-2027)
6.3 North America Valpromide Market Size by Country
6.3.1 North America Valpromide Sales by Country (2016-2027)
6.3.2 North America Valpromide Revenue by Country (2016-2027)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Valpromide Market Size by Type
7.1.1 Europe Valpromide Sales by Type (2016-2027)
7.1.2 Europe Valpromide Revenue by Type (2016-2027)
7.2 Europe Valpromide Market Size by Application
7.2.1 Europe Valpromide Sales by Application (2016-2027)
7.2.2 Europe Valpromide Revenue by Application (2016-2027)
7.3 Europe Valpromide Market Size by Country
7.3.1 Europe Valpromide Sales by Country (2016-2027)
7.3.2 Europe Valpromide Revenue by Country (2016-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Valpromide Market Size by Type
8.1.1 Asia Pacific Valpromide Sales by Type (2016-2027)
8.1.2 Asia Pacific Valpromide Revenue by Type (2016-2027)
8.2 Asia Pacific Valpromide Market Size by Application
8.2.1 Asia Pacific Valpromide Sales by Application (2016-2027)
8.2.2 Asia Pacific Valpromide Revenue by Application (2016-2027)
8.3 Asia Pacific Valpromide Market Size by Region
8.3.1 Asia Pacific Valpromide Sales by Region (2016-2027)
8.3.2 Asia Pacific Valpromide Revenue by Region (2016-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Valpromide Market Size by Type
9.1.1 Latin America Valpromide Sales by Type (2016-2027)
9.1.2 Latin America Valpromide Revenue by Type (2016-2027)
9.2 Latin America Valpromide Market Size by Application
9.2.1 Latin America Valpromide Sales by Application (2016-2027)
9.2.2 Latin America Valpromide Revenue by Application (2016-2027)
9.3 Latin America Valpromide Market Size by Country
9.3.1 Latin America Valpromide Sales by Country (2016-2027)
9.3.2 Latin America Valpromide Revenue by Country (2016-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Valpromide Market Size by Type
10.1.1 Middle East and Africa Valpromide Sales by Type (2016-2027)
10.1.2 Middle East and Africa Valpromide Revenue by Type (2016-2027)
10.2 Middle East and Africa Valpromide Market Size by Application
10.2.1 Middle East and Africa Valpromide Sales by Application (2016-2027)
10.2.2 Middle East and Africa Valpromide Revenue by Application (2016-2027)
10.3 Middle East and Africa Valpromide Market Size by Country
10.3.1 Middle East and Africa Valpromide Sales by Country (2016-2027)
10.3.2 Middle East and Africa Valpromide Revenue by Country (2016-2027)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 China Resources Double-Crane Pharmaceutical Co., Ltd.
11.1.1 China Resources Double-Crane Pharmaceutical Co., Ltd. Corporation Information
11.1.2 China Resources Double-Crane Pharmaceutical Co., Ltd. Overview
11.1.3 China Resources Double-Crane Pharmaceutical Co., Ltd. Valpromide Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 China Resources Double-Crane Pharmaceutical Co., Ltd. Valpromide Product Description
11.1.5 China Resources Double-Crane Pharmaceutical Co., Ltd. Recent Developments
11.2 Beijing Sail Biopharmaceutical Co., Ltd.
11.2.1 Beijing Sail Biopharmaceutical Co., Ltd. Corporation Information
11.2.2 Beijing Sail Biopharmaceutical Co., Ltd. Overview
11.2.3 Beijing Sail Biopharmaceutical Co., Ltd. Valpromide Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 Beijing Sail Biopharmaceutical Co., Ltd. Valpromide Product Description
11.2.5 Beijing Sail Biopharmaceutical Co., Ltd. Recent Developments
11.3 Hunan Xiangzhong Pharmaceutical Co., Ltd.
11.3.1 Hunan Xiangzhong Pharmaceutical Co., Ltd. Corporation Information
11.3.2 Hunan Xiangzhong Pharmaceutical Co., Ltd. Overview
11.3.3 Hunan Xiangzhong Pharmaceutical Co., Ltd. Valpromide Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 Hunan Xiangzhong Pharmaceutical Co., Ltd. Valpromide Product Description
11.3.5 Hunan Xiangzhong Pharmaceutical Co., Ltd. Recent Developments
11.4 Shanxi Luliang Traditional Chinese Medicine Factory
11.4.1 Shanxi Luliang Traditional Chinese Medicine Factory Corporation Information
11.4.2 Shanxi Luliang Traditional Chinese Medicine Factory Overview
11.4.3 Shanxi Luliang Traditional Chinese Medicine Factory Valpromide Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 Shanxi Luliang Traditional Chinese Medicine Factory Valpromide Product Description
11.4.5 Shanxi Luliang Traditional Chinese Medicine Factory Recent Developments
11.5 Hunan Hansen Pharmaceutical Co., Ltd.
11.5.1 Hunan Hansen Pharmaceutical Co., Ltd. Corporation Information
11.5.2 Hunan Hansen Pharmaceutical Co., Ltd. Overview
11.5.3 Hunan Hansen Pharmaceutical Co., Ltd. Valpromide Sales, Price, Revenue and Gross Margin (2016-2021)
11.5.4 Hunan Hansen Pharmaceutical Co., Ltd. Valpromide Product Description
11.5.5 Hunan Hansen Pharmaceutical Co., Ltd. Recent Developments
11.6 Hunan Dino Pharmaceutical Co., Ltd.
11.6.1 Hunan Dino Pharmaceutical Co., Ltd. Corporation Information
11.6.2 Hunan Dino Pharmaceutical Co., Ltd. Overview
11.6.3 Hunan Dino Pharmaceutical Co., Ltd. Valpromide Sales, Price, Revenue and Gross Margin (2016-2021)
11.6.4 Hunan Dino Pharmaceutical Co., Ltd. Valpromide Product Description
11.6.5 Hunan Dino Pharmaceutical Co., Ltd. Recent Developments
11.7 Novartis Pharmaceuticals
11.7.1 Novartis Pharmaceuticals Corporation Information
11.7.2 Novartis Pharmaceuticals Overview
11.7.3 Novartis Pharmaceuticals Valpromide Sales, Price, Revenue and Gross Margin (2016-2021)
11.7.4 Novartis Pharmaceuticals Valpromide Product Description
11.7.5 Novartis Pharmaceuticals Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Valpromide Value Chain Analysis
12.2 Valpromide Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Valpromide Production Mode & Process
12.4 Valpromide Sales and Marketing
12.4.1 Valpromide Sales Channels
12.4.2 Valpromide Distributors
12.5 Valpromide Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Valpromide Industry Trends
13.2 Valpromide Market Drivers
13.3 Valpromide Market Challenges
13.4 Valpromide Market Restraints
14 Key Findings in The Global Valpromide Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Table 1. Global Valpromide Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Pill
Table 3. Major Manufacturers of Capsule
Table 4. Major Manufacturers of Suppository
Table 5. Global Valpromide Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)
Table 6. Global Valpromide Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 7. Global Valpromide Sales by Region (2016-2021) & (K Units)
Table 8. Global Valpromide Sales Market Share by Region (2016-2021)
Table 9. Global Valpromide Sales by Region (2022-2027) & (K Units)
Table 10. Global Valpromide Sales Market Share by Region (2022-2027)
Table 11. Global Valpromide Revenue by Region (2016-2021) & (US$ Million)
Table 12. Global Valpromide Revenue Market Share by Region (2016-2021)
Table 13. Global Valpromide Revenue by Region (2022-2027) & (US$ Million)
Table 14. Global Valpromide Revenue Market Share by Region (2022-2027)
Table 15. Global Valpromide Sales by Manufacturers (2016-2021) & (K Units)
Table 16. Global Valpromide Sales Share by Manufacturers (2016-2021)
Table 17. Global Valpromide Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 18. Global Valpromide Revenue Share by Manufacturers (2016-2021)
Table 19. Valpromide Price by Manufacturers 2016-2021 (US$/Unit)
Table 20. Global Valpromide Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 21. Global Valpromide by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Valpromide as of 2020)
Table 22. Valpromide Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Valpromide Product Offered
Table 24. Date of Manufacturers Enter into Valpromide Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Valpromide Sales by Type (2016-2021) & (K Units)
Table 27. Global Valpromide Sales by Type (2022-2027) & (K Units)
Table 28. Global Valpromide Sales Share by Type (2016-2021)
Table 29. Global Valpromide Sales Share by Type (2022-2027)
Table 30. Global Valpromide Revenue by Type (2016-2021) & (US$ Million)
Table 31. Global Valpromide Revenue by Type (2022-2027) & (US$ Million)
Table 32. Global Valpromide Revenue Share by Type (2016-2021)
Table 33. Global Valpromide Revenue Share by Type (2022-2027)
Table 34. Valpromide Price by Type (2016-2021) & (US$/Unit)
Table 35. Global Valpromide Price Forecast by Type (2022-2027) & (US$/Unit)
Table 36. Global Valpromide Sales by Application (2016-2021) & (K Units)
Table 37. Global Valpromide Sales by Application (2022-2027) & (K Units)
Table 38. Global Valpromide Sales Share by Application (2016-2021)
Table 39. Global Valpromide Sales Share by Application (2022-2027)
Table 40. Global Valpromide Revenue by Application (2016-2021) & (US$ Million)
Table 41. Global Valpromide Revenue by Application (2022-2027) & (US$ Million)
Table 42. Global Valpromide Revenue Share by Application (2016-2021)
Table 43. Global Valpromide Revenue Share by Application (2022-2027)
Table 44. Valpromide Price by Application (2016-2021) & (US$/Unit)
Table 45. Global Valpromide Price Forecast by Application (2022-2027) & (US$/Unit)
Table 46. North America Valpromide Sales by Type (2016-2021) & (K Units)
Table 47. North America Valpromide Sales by Type (2022-2027) & (K Units)
Table 48. North America Valpromide Revenue by Type (2016-2021) & (US$ Million)
Table 49. North America Valpromide Revenue by Type (2022-2027) & (US$ Million)
Table 50. North America Valpromide Sales by Application (2016-2021) & (K Units)
Table 51. North America Valpromide Sales by Application (2022-2027) & (K Units)
Table 52. North America Valpromide Revenue by Application (2016-2021) & (US$ Million)
Table 53. North America Valpromide Revenue by Application (2022-2027) & (US$ Million)
Table 54. North America Valpromide Sales by Country (2016-2021) & (K Units)
Table 55. North America Valpromide Sales by Country (2022-2027) & (K Units)
Table 56. North America Valpromide Revenue by Country (2016-2021) & (US$ Million)
Table 57. North America Valpromide Revenue by Country (2022-2027) & (US$ Million)
Table 58. Europe Valpromide Sales by Type (2016-2021) & (K Units)
Table 59. Europe Valpromide Sales by Type (2022-2027) & (K Units)
Table 60. Europe Valpromide Revenue by Type (2016-2021) & (US$ Million)
Table 61. Europe Valpromide Revenue by Type (2022-2027) & (US$ Million)
Table 62. Europe Valpromide Sales by Application (2016-2021) & (K Units)
Table 63. Europe Valpromide Sales by Application (2022-2027) & (K Units)
Table 64. Europe Valpromide Revenue by Application (2016-2021) & (US$ Million)
Table 65. Europe Valpromide Revenue by Application (2022-2027) & (US$ Million)
Table 66. Europe Valpromide Sales by Country (2016-2021) & (K Units)
Table 67. Europe Valpromide Sales by Country (2022-2027) & (K Units)
Table 68. Europe Valpromide Revenue by Country (2016-2021) & (US$ Million)
Table 69. Europe Valpromide Revenue by Country (2022-2027) & (US$ Million)
Table 70. Asia Pacific Valpromide Sales by Type (2016-2021) & (K Units)
Table 71. Asia Pacific Valpromide Sales by Type (2022-2027) & (K Units)
Table 72. Asia Pacific Valpromide Revenue by Type (2016-2021) & (US$ Million)
Table 73. Asia Pacific Valpromide Revenue by Type (2022-2027) & (US$ Million)
Table 74. Asia Pacific Valpromide Sales by Application (2016-2021) & (K Units)
Table 75. Asia Pacific Valpromide Sales by Application (2022-2027) & (K Units)
Table 76. Asia Pacific Valpromide Revenue by Application (2016-2021) & (US$ Million)
Table 77. Asia Pacific Valpromide Revenue by Application (2022-2027) & (US$ Million)
Table 78. Asia Pacific Valpromide Sales by Region (2016-2021) & (K Units)
Table 79. Asia Pacific Valpromide Sales by Region (2022-2027) & (K Units)
Table 80. Asia Pacific Valpromide Revenue by Region (2016-2021) & (US$ Million)
Table 81. Asia Pacific Valpromide Revenue by Region (2022-2027) & (US$ Million)
Table 82. Latin America Valpromide Sales by Type (2016-2021) & (K Units)
Table 83. Latin America Valpromide Sales by Type (2022-2027) & (K Units)
Table 84. Latin America Valpromide Revenue by Type (2016-2021) & (US$ Million)
Table 85. Latin America Valpromide Revenue by Type (2022-2027) & (US$ Million)
Table 86. Latin America Valpromide Sales by Application (2016-2021) & (K Units)
Table 87. Latin America Valpromide Sales by Application (2022-2027) & (K Units)
Table 88. Latin America Valpromide Revenue by Application (2016-2021) & (US$ Million)
Table 89. Latin America Valpromide Revenue by Application (2022-2027) & (US$ Million)
Table 90. Latin America Valpromide Sales by Country (2016-2021) & (K Units)
Table 91. Latin America Valpromide Sales by Country (2022-2027) & (K Units)
Table 92. Latin America Valpromide Revenue by Country (2016-2021) & (US$ Million)
Table 93. Latin America Valpromide Revenue by Country (2022-2027) & (US$ Million)
Table 94. Middle East and Africa Valpromide Sales by Type (2016-2021) & (K Units)
Table 95. Middle East and Africa Valpromide Sales by Type (2022-2027) & (K Units)
Table 96. Middle East and Africa Valpromide Revenue by Type (2016-2021) & (US$ Million)
Table 97. Middle East and Africa Valpromide Revenue by Type (2022-2027) & (US$ Million)
Table 98. Middle East and Africa Valpromide Sales by Application (2016-2021) & (K Units)
Table 99. Middle East and Africa Valpromide Sales by Application (2022-2027) & (K Units)
Table 100. Middle East and Africa Valpromide Revenue by Application (2016-2021) & (US$ Million)
Table 101. Middle East and Africa Valpromide Revenue by Application (2022-2027) & (US$ Million)
Table 102. Middle East and Africa Valpromide Sales by Country (2016-2021) & (K Units)
Table 103. Middle East and Africa Valpromide Sales by Country (2022-2027) & (K Units)
Table 104. Middle East and Africa Valpromide Revenue by Country (2016-2021) & (US$ Million)
Table 105. Middle East and Africa Valpromide Revenue by Country (2022-2027) & (US$ Million)
Table 106. China Resources Double-Crane Pharmaceutical Co., Ltd. Corporation Information
Table 107. China Resources Double-Crane Pharmaceutical Co., Ltd. Description and Major Businesses
Table 108. China Resources Double-Crane Pharmaceutical Co., Ltd. Valpromide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 109. China Resources Double-Crane Pharmaceutical Co., Ltd. Valpromide Product
Table 110. China Resources Double-Crane Pharmaceutical Co., Ltd. Recent Developments
Table 111. Beijing Sail Biopharmaceutical Co., Ltd. Corporation Information
Table 112. Beijing Sail Biopharmaceutical Co., Ltd. Description and Major Businesses
Table 113. Beijing Sail Biopharmaceutical Co., Ltd. Valpromide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 114. Beijing Sail Biopharmaceutical Co., Ltd. Valpromide Product
Table 115. Beijing Sail Biopharmaceutical Co., Ltd. Recent Developments
Table 116. Hunan Xiangzhong Pharmaceutical Co., Ltd. Corporation Information
Table 117. Hunan Xiangzhong Pharmaceutical Co., Ltd. Description and Major Businesses
Table 118. Hunan Xiangzhong Pharmaceutical Co., Ltd. Valpromide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 119. Hunan Xiangzhong Pharmaceutical Co., Ltd. Valpromide Product
Table 120. Hunan Xiangzhong Pharmaceutical Co., Ltd. Recent Developments
Table 121. Shanxi Luliang Traditional Chinese Medicine Factory Corporation Information
Table 122. Shanxi Luliang Traditional Chinese Medicine Factory Description and Major Businesses
Table 123. Shanxi Luliang Traditional Chinese Medicine Factory Valpromide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 124. Shanxi Luliang Traditional Chinese Medicine Factory Valpromide Product
Table 125. Shanxi Luliang Traditional Chinese Medicine Factory Recent Developments
Table 126. Hunan Hansen Pharmaceutical Co., Ltd. Corporation Information
Table 127. Hunan Hansen Pharmaceutical Co., Ltd. Description and Major Businesses
Table 128. Hunan Hansen Pharmaceutical Co., Ltd. Valpromide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 129. Hunan Hansen Pharmaceutical Co., Ltd. Valpromide Product
Table 130. Hunan Hansen Pharmaceutical Co., Ltd. Recent Developments
Table 131. Hunan Dino Pharmaceutical Co., Ltd. Corporation Information
Table 132. Hunan Dino Pharmaceutical Co., Ltd. Description and Major Businesses
Table 133. Hunan Dino Pharmaceutical Co., Ltd. Valpromide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 134. Hunan Dino Pharmaceutical Co., Ltd. Valpromide Product
Table 135. Hunan Dino Pharmaceutical Co., Ltd. Recent Developments
Table 136. Novartis Pharmaceuticals Corporation Information
Table 137. Novartis Pharmaceuticals Description and Major Businesses
Table 138. Novartis Pharmaceuticals Valpromide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 139. Novartis Pharmaceuticals Valpromide Product
Table 140. Novartis Pharmaceuticals Recent Developments
Table 141. Key Raw Materials Lists
Table 142. Raw Materials Key Suppliers Lists
Table 143. Valpromide Distributors List
Table 144. Valpromide Customers List
Table 145. Valpromide Market Trends
Table 146. Valpromide Market Drivers
Table 147. Valpromide Market Challenges
Table 148. Valpromide Market Restraints
Table 149. Research Programs/Design for This Report
Table 150. Key Data Information from Secondary Sources
Table 151. Key Data Information from Primary Sources
List of Figures
Figure 1. Valpromide Product Picture
Figure 2. Global Valpromide Market Share by Type in 2020 & 2027
Figure 3. Pill Product Picture
Figure 4. Capsule Product Picture
Figure 5. Suppository Product Picture
Figure 6. Global Valpromide Market Share by Application in 2020 & 2027
Figure 7. Hospital
Figure 8. Pharmacy
Figure 9. Others
Figure 10. Valpromide Report Years Considered
Figure 11. Global Valpromide Sales 2016-2027 (K Units)
Figure 12. Global Valpromide Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Valpromide Revenue 2016-2027 (US$ Million)
Figure 14. Global Valpromide Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 15. Global Valpromide Sales Market Share by Region (2016-2021)
Figure 16. Global Valpromide Sales Market Share by Region (2022-2027)
Figure 17. North America Valpromide Sales YoY (2016-2027) & (K Units)
Figure 18. North America Valpromide Revenue YoY (2016-2027) & (US$ Million)
Figure 19. Europe Valpromide Sales YoY (2016-2027) & (K Units)
Figure 20. Europe Valpromide Revenue YoY (2016-2027) & (US$ Million)
Figure 21. Asia-Pacific Valpromide Sales YoY (2016-2027) & (K Units)
Figure 22. Asia-Pacific Valpromide Revenue YoY (2016-2027) & (US$ Million)
Figure 23. Latin America Valpromide Sales YoY (2016-2027) & (K Units)
Figure 24. Latin America Valpromide Revenue YoY (2016-2027) & (US$ Million)
Figure 25. Middle East & Africa Valpromide Sales YoY (2016-2027) & (K Units)
Figure 26. Middle East & Africa Valpromide Revenue YoY (2016-2027) & (US$ Million)
Figure 27. The Top 10 and Top 5 Players Market Share by Valpromide Sales in 2020
Figure 28. The Top 10 and Top 5 Players Market Share by Valpromide Revenue in 2020
Figure 29. Valpromide Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 30. Global Valpromide Sales Market Share by Type (2016-2027)
Figure 31. Global Valpromide Revenue Market Share by Type (2016-2027)
Figure 32. Global Valpromide Sales Market Share by Application (2016-2027)
Figure 33. Global Valpromide Revenue Market Share by Application (2016-2027)
Figure 34. North America Valpromide Sales Market Share by Type (2016-2027)
Figure 35. North America Valpromide Revenue Market Share by Type (2016-2027)
Figure 36. North America Valpromide Sales Market Share by Application (2016-2027)
Figure 37. North America Valpromide Revenue Market Share by Application (2016-2027)
Figure 38. North America Valpromide Sales Share by Country (2016-2027)
Figure 39. North America Valpromide Revenue Share by Country (2016-2027)
Figure 40. United States Valpromide Revenue (2016-2027) & (US$ Million)
Figure 41. Canada Valpromide Revenue (2016-2027) & (US$ Million)
Figure 42. Europe Valpromide Sales Market Share by Type (2016-2027)
Figure 43. Europe Valpromide Revenue Market Share by Type (2016-2027)
Figure 44. Europe Valpromide Sales Market Share by Application (2016-2027)
Figure 45. Europe Valpromide Revenue Market Share by Application (2016-2027)
Figure 46. Europe Valpromide Sales Share by Country (2016-2027)
Figure 47. Europe Valpromide Revenue Share by Country (2016-2027)
Figure 48. Germany Valpromide Revenue (2016-2027) & (US$ Million)
Figure 49. France Valpromide Revenue (2016-2027) & (US$ Million)
Figure 50. U.K. Valpromide Revenue (2016-2027) & (US$ Million)
Figure 51. Italy Valpromide Revenue (2016-2027) & (US$ Million)
Figure 52. Russia Valpromide Revenue (2016-2027) & (US$ Million)
Figure 53. Asia Pacific Valpromide Sales Market Share by Type (2016-2027)
Figure 54. Asia Pacific Valpromide Revenue Market Share by Type (2016-2027)
Figure 55. Asia Pacific Valpromide Sales Market Share by Application (2016-2027)
Figure 56. Asia Pacific Valpromide Revenue Market Share by Application (2016-2027)
Figure 57. Asia Pacific Valpromide Sales Share by Region (2016-2027)
Figure 58. Asia Pacific Valpromide Revenue Share by Region (2016-2027)
Figure 59. China Valpromide Revenue (2016-2027) & (US$ Million)
Figure 60. Japan Valpromide Revenue (2016-2027) & (US$ Million)
Figure 61. South Korea Valpromide Revenue (2016-2027) & (US$ Million)
Figure 62. India Valpromide Revenue (2016-2027) & (US$ Million)
Figure 63. Australia Valpromide Revenue (2016-2027) & (US$ Million)
Figure 64. China Taiwan Valpromide Revenue (2016-2027) & (US$ Million)
Figure 65. Indonesia Valpromide Revenue (2016-2027) & (US$ Million)
Figure 66. Thailand Valpromide Revenue (2016-2027) & (US$ Million)
Figure 67. Malaysia Valpromide Revenue (2016-2027) & (US$ Million)
Figure 68. Latin America Valpromide Sales Market Share by Type (2016-2027)
Figure 69. Latin America Valpromide Revenue Market Share by Type (2016-2027)
Figure 70. Latin America Valpromide Sales Market Share by Application (2016-2027)
Figure 71. Latin America Valpromide Revenue Market Share by Application (2016-2027)
Figure 72. Latin America Valpromide Sales Share by Country (2016-2027)
Figure 73. Latin America Valpromide Revenue Share by Country (2016-2027)
Figure 74. Mexico Valpromide Revenue (2016-2027) & (US$ Million)
Figure 75. Brazil Valpromide Revenue (2016-2027) & (US$ Million)
Figure 76. Argentina Valpromide Revenue (2016-2027) & (US$ Million)
Figure 77. Colombia Valpromide Revenue (2016-2027) & (US$ Million)
Figure 78. Middle East and Africa Valpromide Sales Market Share by Type (2016-2027)
Figure 79. Middle East and Africa Valpromide Revenue Market Share by Type (2016-2027)
Figure 80. Middle East and Africa Valpromide Sales Market Share by Application (2016-2027)
Figure 81. Middle East and Africa Valpromide Revenue Market Share by Application (2016-2027)
Figure 82. Middle East and Africa Valpromide Sales Share by Country (2016-2027)
Figure 83. Middle East and Africa Valpromide Revenue Share by Country (2016-2027)
Figure 84. Turkey Valpromide Revenue (2016-2027) & (US$ Million)
Figure 85. Saudi Arabia Valpromide Revenue (2016-2027) & (US$ Million)
Figure 86. UAE Valpromide Revenue (2016-2027) & (US$ Million)
Figure 87. Valpromide Value Chain
Figure 88. Valpromide Production Process
Figure 89. Channels of Distribution
Figure 90. Distributors Profiles
Figure 91. Bottom-up and Top-down Approaches for This Report
Figure 92. Data Triangulation
Figure 93. Key Executives Interviewed
世界のバルプロミド市場インサイト・予測（～2027年） Valpromide is used to prevent and treat various types of epilepsy, with fast onset, strong effect and low toxicity. Market Analysis and Insights: Global Valpromide Market The global Valpromide market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, g…- 世界のグアンファシン徐放錠市場インサイト・予測（～2027年） Guanfacine Extended-Release Pill is used to treat attention deficit hyperactivity disorder (ADHD) in children and adolescents aged 6 to 17 years. Market Analysis and Insights: Global Guanfacine Extended-Release Pill Market The global Guanfacine Extended-Release Pill market is valued at US$ XX millio…
- 世界のグアンファシン徐放錠市場インサイト・予測（～2027年） Guanfacine Extended-Release Pill is used to treat attention deficit hyperactivity disorder (ADHD) in children and adolescents aged 6 to 17 years. Market Analysis and Insights: Global Guanfacine Extended-Release Pill Market The global Guanfacine Extended-Release Pill market is valued at US$ XX millio…
- 世界の初乳カプセル市場インサイト・予測（～2027年） Market Analysis and Insights: Global Colostrum Capsule Market The global Colostrum Capsule market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027. Global Colostrum Capsule Scope and Segment Colostrum Capsule…
- 世界の錠剤＆カプセル検査装置市場インサイト・予測（～2027年） Market Analysis and Insights: Global Tablet and Capsule Inspection Equipment Market The global Tablet and Capsule Inspection Equipment market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027. Global Tablet an…